Latest News

Cooperation on Projects | Leto Laboratories and Hanson Pharmaceutical Entered into Cooperation in Developing a New Drug for Metabolic Diseases

In September 2021, the Hanson Pharmaceutical Group Co., Ltd. (HKEX: 3692) ("Hanson Pharmaceutical") and Leto Laboratories Co., Ltd. ("Leto Laboratories") signed a co-development agreement, in which the parties agreed to carry out a cooperation on metabolic disease projects to facilitate the development and production of a new drug molecule.

Published: September 13, 2021

Latest News

Leto Laboratories Raises over $15 Million in Series B+ Financing Round for Protein Engineering

Leto Laboratories Co., Ltd. ("Leto Labs") announced the closing of a Series B+ financing of over $15.64 Million (RMB 100 million) from China Capital Management Co., Ltd. The company intends to use the proceeds to continue the development of its polypeptides and anticancer cytokines pipeline.

Published: August 4, 2021